Anti‐EGFR therapy vs placebo or usual care
Lymphopenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in lymphopenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
- Anti‐epidermal growth factor receptor therapy for glioblastoma in adults 2020 · Cochrane Headline outcomes onlyOR 0.97 [0.19, 4.81]4 studies · 1146 participantsLow